NMS Labs Launches New Test To Monitor BPA Levels in Humans
NMS Labs said that this is a timely release due to the FDA’s recent reversal of its position on BPA’s potentially harmful effects and the National Toxicology Program’s
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.
The company-owned 30,000 square-foot facility is expected to provide clients with access to multiple clean room manufacturing suites, each with independent air-handling and laboratory systems, to support PCT’s
5-fluorouracil (5-FU) is used in many chemotherapy regimens, including FOLFOX (folinic acid, fluorouracil and oxaliplatin), FOLFOX6, and FOLFIRI (folinic acid, fluorouracil and irinotecan), and is used extensively in